Fundraising FoxGeninus
3 known investors
Find your way into Geninus
Sign up to find every way you can get introduced to Geninus
- Your email: who you already know at Geninus, and who your contacts know
- 2nd- and 3rd-degree connections: people you know who worked, studied or invested with the Geninus team
- Your LinkedIn: the connections who can make the intro for you
We rank every route by how warm it is, so you raise on warm intros instead of cold emails.
Geninus develops IntelliMed, a platform that uses multimodal spatial transcriptomics and patient data to discover novel drug targets for oncology, particularly for modalities like TCEs and ADCs. The platform combines spatial genomics, protein profiling, and clinical outcomes to enable target discovery with reduced biological risk.
Founders & leadership
Investors · 3
Frequently asked questions
- What does Geninus do?
- Geninus develops IntelliMed, a platform that uses multimodal spatial transcriptomics and patient data to discover novel drug targets for oncology, particularly for modalities like TCEs and ADCs. The platform combines spatial genomics, protein profiling, and clinical outcomes to enable target discovery with reduced biological risk.
- Who founded Geninus?
- Geninus was founded by Woong Yang Park.
- Who are Geninus's investors?
- Geninus's investors include Aju IB Invesment Corporation, IMM Investment Japan, Solidus Investment.